BACKGROUND: Frequent non-pathogenic genetic variants may act as moderators of phenotypic severity for complex disorders such as autism spectrum disorder (ASD). We previously identified polymorphisms affecting mRNA expression of candidate genes, including tryptophan hydroxylase 2 (TPH2), dopamine beta hydroxylase (DBH), and dopamine transporter (DAT, SLC6A3). METHOD: We compare genotypes and (1) clinical response to atomoxetine, (2) scores from the Autism Diagnostic Interview-Revised (ADI-R), and (3) severity of Attention Deficit Hyperactivity Disorder (ADHD) symptoms in a cohort of patients with ASD from multiple study sites. RESULTS: There was no association between CYP2D6 metabolizer status and atomoxetine response. TPH2 rs7305115 genotype was associated with ADI-R Restrictive/Repetitive Behavior score (p=0.03). DBH rs1611115 genotype was associated with ADI-R Social score (p=0.002) and Restrictive/Repetitive Behavior score (p=0.04). The DAT intron 8 5/6 repeat was associated with ADHD symptoms (ABC Hyperactivity p=0.01 and SNAP ADHD p=0.03), replicating a previous finding. CONCLUSIONS: We find associations between ASD phenotypes and regulatory variants in catecholamine biosynthesis genes. This work may help guide future genetics studies related to ASD.
BACKGROUND: Frequent non-pathogenic genetic variants may act as moderators of phenotypic severity for complex disorders such as autism spectrum disorder (ASD). We previously identified polymorphisms affecting mRNA expression of candidate genes, including tryptophan hydroxylase 2 (TPH2), dopamine beta hydroxylase (DBH), and dopamine transporter (DAT, SLC6A3). METHOD: We compare genotypes and (1) clinical response to atomoxetine, (2) scores from the Autism Diagnostic Interview-Revised (ADI-R), and (3) severity of Attention Deficit Hyperactivity Disorder (ADHD) symptoms in a cohort of patients with ASD from multiple study sites. RESULTS: There was no association between CYP2D6 metabolizer status and atomoxetine response. TPH2 rs7305115 genotype was associated with ADI-R Restrictive/Repetitive Behavior score (p=0.03). DBH rs1611115 genotype was associated with ADI-R Social score (p=0.002) and Restrictive/Repetitive Behavior score (p=0.04). The DAT intron 8 5/6 repeat was associated with ADHD symptoms (ABC Hyperactivity p=0.01 and SNAP ADHD p=0.03), replicating a previous finding. CONCLUSIONS: We find associations between ASD phenotypes and regulatory variants in catecholamine biosynthesis genes. This work may help guide future genetics studies related to ASD.
Authors: Benjamin L Handen; Michael G Aman; L Eugene Arnold; Susan L Hyman; Rameshwari V Tumuluru; Luc Lecavalier; Patricia Corbett-Dick; Xueliang Pan; Jill A Hollway; Kristin A Buchan-Page; Laura B Silverman; Nicole V Brown; Robert R Rice; Jessica Hellings; Daniel W Mruzek; Sarah McAuliffe-Bellin; Elizabeth A Hurt; Melissa M Ryan; Lynne Levato; Tristram Smith Journal: J Am Acad Child Adolesc Psychiatry Date: 2015-09-03 Impact factor: 8.829
Authors: Nicolas Ramoz; Guiqing Cai; Jennifer G Reichert; Thomas E Corwin; Lauren A Kryzak; Christopher J Smith; Jeremy M Silverman; Eric Hollander; Joseph D Buxbaum Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2006-12-05 Impact factor: 3.568
Authors: Hilary Coon; Diane Dunn; Janet Lainhart; Judith Miller; Cindy Hamil; Agatino Battaglia; Raffaella Tancredi; Mark F Leppert; Robert Weiss; William McMahon Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2005-05-05 Impact factor: 3.568
Authors: Flora Tassone; Lihong Qi; Wenting Zhang; Robin L Hansen; Isaac N Pessah; Irva Hertz-Picciotto Journal: Autism Res Date: 2011-04-29 Impact factor: 5.216
Authors: Robert A Moyer; Danxin Wang; Audrey C Papp; Ryan M Smith; Linda Duque; Deborah C Mash; Wolfgang Sadee Journal: Neuropsychopharmacology Date: 2010-12-08 Impact factor: 7.853
Authors: Catherine E Cottrell; Natalie Bir; Elizabeth Varga; Carlos E Alvarez; Samuel Bouyain; Randall Zernzach; Devon L Thrush; Johnna Evans; Michael Trimarchi; Eric M Butter; David Cunningham; Julie M Gastier-Foster; Kim L McBride; Gail E Herman Journal: Autism Res Date: 2011-02-09 Impact factor: 5.216
Authors: Elizabeth S Barrie; David Weinshenker; Anurag Verma; Sarah A Pendergrass; Leslie A Lange; Marylyn D Ritchie; James G Wilson; Helena Kuivaniemi; Gerard Tromp; David J Carey; Glenn S Gerhard; Murray H Brilliant; Scott J Hebbring; Joseph F Cubells; Julia K Pinsonneault; Greg J Norman; Wolfgang Sadee Journal: Circ Res Date: 2014-10-17 Impact factor: 17.367
Authors: W Retz; M Rösler; C Kissling; S Wiemann; R Hünnerkopf; A Coogan; J Thome; C Freitag Journal: J Neural Transm (Vienna) Date: 2007-11-12 Impact factor: 3.575